Clinical Trials Search Results

Results 11-20 of 41 for your search
Show Search Criteria
MAGE-A4ᶜ¹º³²T for Multi-Tumor
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 8 locations
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
Atezolizumab and Bevacizumab in Previously Untreated Metastatic / Unresectable Urothelial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
Phase 1b / 2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 5 locations
Tremelimumab in Treating Patients with Previously Treated Metastatic Urothelial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 3 locations